Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myelogenous Leukemia

Clinical trial condition

Acute Myelogenous Leukemia

Explore clinical trials studying Acute Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

154 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Acute Myelogenous Leukemia trial results

Completed

Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia

NCT00044889

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Los Angeles, California, United States

Washington D.C., District of Columbia, United States

Jacksonville, Florida, United States

Chicago, Illinois, United States

View Trial Details

Completed

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

NCT01090167

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Nagoya Daini Red Cross Hospital Aichi, Japan

National Hospital Organization Nagoya Medical Center Aichi, Japan

University of Fukui Hospital Fukui, Japan

Tokai University Hospital Kanagawa, Japan

View Trial Details

Completed

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

NCT00911066

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +15 more
Locations: Stanford University Medical Center Stanford, California, United States

Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, Illinois, United States

Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)

NCT00882102

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

NCT00360672

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

NCT00334074

Conditions: Acute Myelogenous Leukemia, Blast Crisis, Bone Marrow Diseases, +19 more
Locations: Baylor University Medical Center Dallas, Texas, United States

View Trial Details

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

NCT00968071

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)

NCT00398983

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting

NCT01031498

Conditions: Acute Myelogenous Leukemia, Chemotherapy-induced Nausea and Vomiting, Hematologic Diseases, +13 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections

NCT00418951

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: The University of Texas M D Anderson Cancer Center Houston, Texas, United States

View Trial Details